Welcome, visitor! [ Register | Loginrss

 

Stem Cell Therapeutics Markets

  • Issued By: Aarkstore Enterprise
  • City / State: Navi Mumbai
  • Phone: +919272852585
  • Company Website: http://www.aarkstore.com/
  • Submitted: November 24, 2010 3:15 am

  • FOR IMMEDIATE RELEASE
image

Navi Mumbai, November 24, 2010:

Political and business events presage change for stem cell therapeutics, most notably the expected move by President Barack Obama to lift federal funding restrictions on stem-cell research. The U.S. Congress has also indicated a desire to move forward with stem cell research. The momentum in two branches of American government, along with scientific developments and the competition of world markets presages good market conditions for stem cell research.

With their ability to differentiate and become an ongoing source of cells that make up critical tissues and organs, stem cells have potential for new regenerative therapies and as new research tools for drug developers to test emerging therapies on diseased cells.

While companies have found opportunity outside the U.S., President Bush’s seven year limitations on embryonic stem cell research in the U.S. has limited the U.S. market. Changes in U.S. policy should open up U.S. markets. For market-watchers in the pharmaceutical industry, the question is what potential they have and where they could take the market. Kalorama Information has tackled that question in Stem Cells Therapeutics Markets. Kalorama analyst Alison Sahoo has built models to determine the best case and most likely case scenarios for therapeutic markets for stem cells in the coming years.

This report breaks down forecasted revenues and procedure volumes for stem cell technologies for these segments in the following disease areas:

Cardiovascular disease
Lung disease
Arthritis
Incontinence
Osteoporosis
Diabetes
Cancer
Orthopedics
Infertility
Alzheimer’s disease
Burns (severe)
Lupus
Parkinson’s disease
Liver failure
Multiple sclerosis
Critical limb ischemia
Crohn’s disease
Sickle cell disease
Multiple myeloma
NH lymphoma
Leukemia
Ths report is the result of exclusive interviews with executives in the stem cell industry, a review of medical and company literature, government databases and publications. As part of this comprehensive analysis of stem cell markets, the following companies were profiled:

Aastrom Biosciences
Advanced Cell Technologies
Brainstorm Cell Therapeutics
Celegene
ES Cell International
Medistem
Neostem
Opexa Therapeutics
Osiris Therapeutics
Plureon
Regenetech
Revivicor
Stem Cell Sciences
StemLifeLine
ThermoGenesis
VetCell Bioscience

For more information please visit :

http://www.aarkstore.com/reports/Stem-Cell-Therapeutics-Markets-13481.html

From: Aarkstore Enterprise
Contact: Anna
Ph.No.91927282585
Email: winaarkstore@gmail.com
URL:http://www.aarkstore.com/

Disclaimer: Contents published on Forestlaneshul Press are submitted by our members and we as such are not responsible for the same. If you think the article is a spam or an abuse of our free press release or articles submission system, please report it. You can also submit a press release or article by login in or registering with us. And yes, it's free.

Leave a Reply

To inquire about this Press Release, complete the form below to send a message to the PR Submitter.

Information about this PR

  • PR Submitted by: namrata
  • Member Since: October 27, 2010